Source comparison
MOTS-c vs Direct AMPK Activators: Why the Mechanism Matters
Metformin, AICAR, and resveratrol all activate AMPK. But through different mechanisms, and those differences produce distinct metabolic outcomes. Metformin inhibits Complex I of the electron transport chain, creating real ATP depletion that forces AMPK activat
This comparison does not assign a generated winner or score.
- Metformin, AICAR, and resveratrol all activate AMPK. But through different mechanisms, and those differences produce distinct metabolic outcomes. Metformin inhibits Complex I of the electron transport chain, creating real ATP depletion that forces AMPK activation as a survival response. AICAR is a precursor to ZMP and mimics AMP directly. Resveratrol activates SIRT1, which indirectly activates AMPK through deacetylation.
- MOTS-c is unique because it works through mitochondrial communication. It doesn't inhibit ATP production or mimic AMP structure. It tells the nucleus that mitochondria are under stress, which triggers an adaptive response rather than a compensatory one. The practical difference: metformin can cause GI distress and lactic acidosis because it genuinely impairs mitochondrial respiration. MOTS-c produces metabolic benefits without the adverse events tied to energy substrate manipulation.
- A head-to-head comparison published in Molecular Metabolism (2018) showed that MOTS-c and metformin produced similar improvements in glucose tolerance in high-fat diet mice, but only MOTS-c increased exercise endurance. Metformin-treated mice showed no endurance benefit and higher lactate accumulation during treadmill tests. The MOTS-c AMPK pathway mechanism preserves mitochondrial respiratory capacity while shifting fuel preference, which is why it's being investigated for conditions where metformin fails or causes intolerable side effects.
- MOTS-c
- Mitochondrial retrograde signaling
- ZMP accumulation via ATIC inhibition
- Enhances biogenesis (↑ PGC-1α)
- Increased endurance capacity
- Metformin
- Complex I inhibition
- ATP depletion (↑ AMP:ATP ratio)
- Impairs respiration
- No improvement or decline
- AICAR
- Direct AMP mimetic
- ZMP binding to AMPK gamma subunit
- Neutral (no biogenesis signal)
- Variable (dose-dependent)
- Resveratrol
- SIRT1 activation
- Indirect via NAD+ / AMPK deacetylation
- Promotes biogenesis (mild)
- Modest improvement